Experimental validation of candidate schizophrenia gene ZNF804A as target for hsa-miR-137

Schizophrenia Research

Volumn 141, Issue 1, 2012, Pages 60-64

  Kim, Albert H ^a,b   Parker, Erin K ^a   Williamson, Vernell ^a,b   McMichael, Gowon O ^a   Fanous, Ayman H ^a,d,e,f   Vladimirov, Vladimir I ^a,c  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Gene expression; GWAS; Luciferase; MiRNA; Real time PCR; Schizophrenia

Indexed keywords

CALCIUM CHANNEL; CUB AND SUSHI MULTIPLE DOMAINS 1 PROTEIN; LUCIFERASE; MICRORNA; MICRORNA 137; PROTEIN; SMALL UNTRANSLATED RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR 4; UNCLASSIFIED DRUG; VOLTAGE DEPENDENT CALCIUM CHANNEL L TYPE ALPHA1C SUBUNIT;

ARTICLE; BIPOLAR DISORDER; CHROMOSOME 10 OPEN READING FRAME 26 GENE; COMPUTER MODEL; DNA POLYMORPHISM; GENE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE LOCUS; GENE REPLICATION; GENE TARGETING; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; PREDICTION; PRIORITY JOURNAL; SCHIZOPHRENIA; VALIDATION PROCESS; ZNF804A GENE;

CELL LINE, TRANSFORMED; CELL LINE, TUMOR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; LUCIFERASES; MICRORNAS; MUTAGENESIS; NEUROBLASTOMA; TRANSFECTION;

EID: 84865985475     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2012.06.038     Document Type: Article

References (48)

1. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
2. Berrettini W. Evidence for shared susceptibility in bipolar disorder and schizophrenia. Am. J. Med. Genet. C Semin. Med. Genet. 2003, 123C:59-64.
3. Beveridge N.J., Gardiner E., Carroll A.P., Tooney P.A., Cairns M.J. Schizophrenia is associated with an increase in cortical microRNA biogenesis. Mol. Psychiatry 2010, 15:1176-1189.
4. Brennecke J., Stark A., Russell R.B., Cohen S.M. Principles of microRNA-target recognition. PLoS Biol. 2005, 3:e85.
5. Burmistrova O.A., Goltsov A.Y., Abramova L.I., Kaleda V.G., Orlova V.A., Rogaev E.I. MicroRNA in schizophrenia: genetic and expression analysis of miR-130b (22q 11). Biochem. Mosc. 2007, 72:578-582.
6. Donohoe G., Morris D.W., Corvin A. The psychosis susceptibility gene ZNF804A: associations, functions, and phenotypes. Schizophr. Bull. 2010, 36:904-909.
7. Dreyer J.L. New insights into the roles of microRNAs in drug addiction and neuroplasticity. Genome Med. 2010, 2:92.
8. Ferreira M.A., O'Donovan M.C., Meng Y.A., Jones I.R., Ruderfer D.M., Jones L., Fan J., Kirov G., Perlis R.H., Green E.K., Smoller J.W., Grozeva D., Stone J., Nikolov I., Chambert K., Hamshere M.L., Nimgaonkar V.L., Moskvina V., Thase M.E., Caesar S., Sachs G.S., Franklin J., Gordon-Smith K., Ardlie K.G., Gabriel S.B., Fraser C., Blumenstiel B., Defelice M., Breen G., Gill M., Morris D.W., Elkin A., Muir W.J., Mcghee K.A., Williamson R., MacIntyre D.J., Maclean A.W., St C.D., Robinson M., Van B.M., Pereira A.C., Kandaswamy R., McQuillin A., Collier D.A., Bass N.J., Young A.H., Lawrence J., Ferrier I.N., Anjorin A., Farmer A., Curtis D., Scolnick E.M., McGuffin P., Daly M.J., Corvin A.P., Holmans P.A., Blackwood D.H., Gurling H.M., Owen M.J., Purcell S.M., Sklar P., Craddock N. Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat. Genet. 2008, 40:1056-1058.
9. Girgenti M.J., LoTurco J.J., Maher B.J. ZNF804a regulates expression of the schizophrenia-associated genes PRSS16, COMT, PDE4B, and DRD2. PLoS One 2012, 7:e32404.
10. Hansen T., Olsen L., Lindow M., Jakobsen K.D., Ullum H., Jonsson E., Andreassen O.A., Djurovic S., Melle I., Agartz I., Hall H., Timm S., Wang A.G., Werge T. Brain expressed microRNAs implicated in schizophrenia etiology. PLoS One 2007, 2:e873.
11. Hansen T., Olsen L., Lindow M., Jakobsen K.D., Ullum H., Jonsson E., Andreassen O.A., Djurovic S., Melle I., Agartz I., Hall H., Timm S., Wang A.G., Werge T. Brain expressed microRNAs implicated in schizophrenia etiology. PLoS One 2007, 2:e873.
12. Hill M.J., Bray N.J. Allelic differences in nuclear protein binding at a genome-wide significant risk variant for schizophrenia in ZNF804A. Mol. Psychiatry 2011, 16:787-789.
13. Hill M.J., Jeffries A.R., Dobson R.J., Price J., Bray N.J. Knockdown of the psychosis susceptibility gene ZNF804A alters expression of genes involved in cell adhesion. Hum. Mol. Genet. 2012, 21:1018-1024.
14. Huang Y., Zou Q., Song H., Song F., Wang L., Zhang G., Shen X. A study of miRNAs targets prediction and experimental validation. Protein Cell 2010, 1:979-986.
15. Jablensky A., Sartorius N., Ernberg G., Anker M., Korten A., Cooper J.E., Day R., Bertelsen A. Schizophrenia - manifestations, incidence and course in different cultures - A World-Health-Organization 10-Country Study. Psychol. Med. 1992, 1-97.
16. Jablensky A., Sartorius N., Ernberg G., Anker M., Korten A., Cooper J.E., Day R., Bertelsen A. Schizophrenia - manifestations, incidence and course in different cultures - A World-Health-Organization 10-Country Study. Psychol. Med. 1992, 1-97.
17. Johnson M.B., Kawasawa Y.I., Mason C.E., Krsnik Z., Coppola G., Bogdanovic D., Geschwind D.H., Mane S.M., State M.W., Sestan N. Functional and evolutionary insights into human brain development through global transcriptome analysis. Neuron 2009, 62:494-509.
18. Kato T., Kuratomi G., Kato N. Genetics of bipolar disorder. Drugs Today 2005, 41:335-344.
19. Kendler K.S., O'Neill F.A., Burke J., Murphy B., Duke F., Straub R.E., Shinkwin R., Ni Nuallain M., MacLean C.J., Walsh D. Irish study on high-density schizophrenia families: field methods and power to detect linkage. Am. J. Med. Genet. 1996, 179-190.
20. Kendler K.S., Diehl S.R. The genetics of schizophrenia - a current, genetic-epidemiologic perspective. Schizophr. Bull. 1993, 19:261-285.
21. Kendler K.S., Diehl S.R. The genetics of schizophrenia - a current, genetic-epidemiologic perspective. Schizophr. Bull. 1993, 19:261-285.
22. Kendler K.S., Gruenberg A.M., Tsuang M.T. Psychiatric illness in first-degree relatives of schizophrenic and surgical control patients. A family study using DSM-III criteria. Arch. Gen. Psychiatry 1985, 42:770-779.
23. Kendler K.S., Gruenberg A.M., Kinney D.K. Independent diagnoses of adoptees and relatives as defined by DSM-III in the Provincial and National Samples of the Danish Adoption Study of Schizophrenia. Arch. Gen. Psychiatry 1994, 51:456-468.
24. Kendler K.S., Gruenberg A.M., Kinney D.K. Independent diagnoses of adoptees and relatives as defined by DSM-III in the Provincial and National Samples of the Danish Adoption Study of Schizophrenia. Arch. Gen. Psychiatry 1994, 51:456-468.
25. Kertesz M., Iovino N., Unnerstall U., Gaul U., Segal E. The role of site accessibility in microRNA target recognition. Nat. Genet. 2007, 39:1278-1284.
26. Kety S.S. The significance of genetic factors in the etiology of schizophrenia: results from the national study of adoptees in Denmark. J. Psychiatr. Res. 1987, 21:423-429.
27. Kim A.H., Reimers M., Maher B., Williamson V., McMichael O., McClay J.L., Van den Oord E.J., Riley B.P., Kendler K.S., Vladimirov V.I. MicroRNA expression profiling in the prefrontal cortex of individuals affected with schizophrenia and bipolar disorders. Schizophr. Res. 2010, 124(1-3):183-191.
28. Kwon E., Wang W., Tsai L.H. Validation of schizophrenia-associated genes CSMD1, C10orf26, CACNA1C and TCF4 as miR-137 targets. Mol. Psychiatry 2011, 1-2.
29. Lai E.C. Micro RNAs are complementary to 3' UTR sequence motifs that mediate negative post-transcriptional regulation. Nat. Genet. 2002, 30:363-364.
30. Lencz T., Szeszko P.R., DeRosse P., Burdick K.E., Bromet E.J., Bilder R.M., Malhotra A.K. A schizophrenia risk gene, ZNF804A, influences neuroanatomical and neurocognitive phenotypes. Neuropsychopharmacology 2010, 35:2284-2291.
31. Lewis B.P., Shih I.H., Jones-Rhoades M.W., Bartel D.P., Burge C.B. Prediction of mammalian microRNA targets. Cell 2003, 115:787-798.
32. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
33. Miller B.H., Wahlestedt C. MicroRNA dysregulation in psychiatric disease. Brain Res. 2010, 1338:89-99.
34. O'Donovan M.C., Craddock N., Norton N., Williams H., Peirce T., Moskvina V., Nikolov I., Hamshere M., Carroll L., Georgieva L., Dwyer S., Holmans P., Marchini J.L., Spencer C.C., Howie B., Leung H.T., Hartmann A.M., Moller H.J., Morris D.W., Shi Y., Feng G., Hoffmann P., Propping P., Vasilescu C., Maier W., Rietschel M., Zammit S., Schumacher J., Quinn E.M., Schulze T.G., Williams N.M., Giegling I., Iwata N., Ikeda M., Darvasi A., Shifman S., He L., Duan J., Sanders A.R., Levinson D.F., Gejman P.V., Cichon S., Nothen M.M., Gill M., Corvin A., Rujescu D., Kirov G., Owen M.J., Buccola N.G., Mowry B.J., Freedman R., Amin F., Black D.W., Silverman J.M., Byerley W.F., Cloninger C.R. Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat. Genet. 2008, 40:1053-1055.
35. Perkins D.O., Jeffries C.D., Jarskog L.F., Thomson J.M., Woods K., Newman M.A., Parker J.S., Jin J.P., Hammond S.M. microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder. Genome Biol. 2007, 8(2):R27.
36. Potkin S.G., Macciardi F., Guffanti G., Fallon J.H., Wang Q., Turner J.A., Lakatos A., Miles M.F., Lander A., Vawter M.P., Xie X. Identifying gene regulatory networks in schizophrenia. NeuroImage 2010, 53:839-847.
37. Purcell S.M., Wray N.R., Stone J.L., Visscher P.M., O'Donovan M.C., Sullivan P.F., Sklar P., Ruderfer D.M., McQuillin A., Morris D.W., O'Dushlaine C.T., Corvin A., Holmans P.A., Macgregor S., Gurling H., Blackwood D.H.R., Corvin A., Craddock N.J., Gill M., Hultman C.M., Kirov G.K., Lichtenstein P., Muir W.J., Owen M.J., Pato C.N., Scolnick E.M., St Clair D., Craddock N.J., Holmans P.A., Williams N.M., Georgieva L., Nikolov I., Norton N., Williams H., Toncheva D., Milanova V., Hultman C.M., Lichtenstein P., Thelander E.F., Sullivan P., Kenny E., Quinn E.M., Gill M., Corvin A., Choudhury K., Datta S., Pimm J., Thirumalai S., Puri V., Krasucki R., Lawrence J., Quested D., Bass N., Crombie C., Fraser G., Kuan S.L., Walker N., Blackwood D.H.R., Muir W.J., Mcghee K.A., Pickard B., Malloy P., Maclean A.W., Van Beck M., Wray N.R., Macgregor S., Visscher P.M., Pato M.T., Medeiros H., Middleton F., Carvalho C., Morley C., Fanous A., Conti D., Knowles J.A., Ferreira C.P., Macedo A., Azevedo M.H., Kirby A.N., Ferreira M.A.R., Daly M.J., Chambert K., Kuruvilla F., Gabriel S.B., Ardlie K., Moran J.L., Daly M.J., Scolnick E.M. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009, 460:748-752.
38. Purcell S.M., Wray N.R., Stone J.L., Visscher P.M., O'Donovan M.C., Sullivan P.F., Sklar P., Ruderfer D.M., McQuillin A., Morris D.W., O'Dushlaine C.T., Corvin A., Holmans P.A., Macgregor S., Gurling H., Blackwood D.H.R., Corvin A., Craddock N.J., Gill M., Hultman C.M., Kirov G.K., Lichtenstein P., Muir W.J., Owen M.J., Pato C.N., Scolnick E.M., St Clair D., Craddock N.J., Holmans P.A., Williams N.M., Georgieva L., Nikolov I., Norton N., Williams H., Toncheva D., Milanova V., Hultman C.M., Lichtenstein P., Thelander E.F., Sullivan P., Kenny E., Quinn E.M., Gill M., Corvin A., Choudhury K., Datta S., Pimm J., Thirumalai S., Puri V., Krasucki R., Lawrence J., Quested D., Bass N., Crombie C., Fraser G., Kuan S.L., Walker N., Blackwood D.H.R., Muir W.J., Mcghee K.A., Pickard B., Malloy P., Maclean A.W., Van Beck M., Wray N.R., Macgregor S., Visscher P.M., Pato M.T., Medeiros H., Middleton F., Carvalho C., Morley C., Fanous A., Conti D., Knowles J.A., Ferreira C.P., Macedo A., Azevedo M.H., Kirby A.N., Ferreira M.A.R., Daly M.J., Chambert K., Kuruvilla F., Gabriel S.B., Ardlie K., Moran J.L., Daly M.J., Scolnick E.M. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009, 460:748-752.
39. Ramakers C., Ruijter J.M., Deprez R.H., Moorman A.F. Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data. Neurosci. Lett. 2003, 339:62-66.
40. Riley B., Thiselton D., Maher B.S., Bigdeli T., Wormley B., McMichael G.O., Fanous A.H., Vladimirov V., O'Neill F.A., Walsh D., Kendler K.S. Replication of association between schizophrenia and ZNF804A in the Irish Case-Control Study of Schizophrenia sample. Mol. Psychiatry 2010, 15:29-37.
41. Ripke S., Sanders A.R., Kendler K.S., Levinson D.F., Sklar P., Holmans P.A., Lin D.Y., Duan J., Ophoff R.A., Andreassen O.A., Scolnick E., Cichon S., St C.D., Corvin A., Gurling H., Werge T., Rujescu D., Blackwood D.H., Pato C.N., Malhotra A.K., Purcell S., Dudbridge F., Neale B.M., Rossin L., Visscher P.M., Posthuma D., Ruderfer D.M., Fanous A., Stefansson H., Steinberg S., Mowry B.J., Golimbet V., De H.M., Jonsson E.G., Bitter I., Pietilainen O.P., Collier D.A., Tosato S., Agartz I., Albus M., Alexander M., Amdur R.L., Amin F., Bass N., Bergen S.E., Black D.W., Borglum A.D., Brown M.A., Bruggeman R., Buccola N.G., Byerley W.F., Cahn W., Cantor R.M., Carr V.J., Catts S.V., Choudhury K., Cloninger C.R., Cormican P., Craddock N., Danoy P.A., Datta S., de H.L., Demontis D., Dikeos D., Djurovic S., Donnelly P., Donohoe G., Duong L., Dwyer S., Fink-Jensen A., Freedman R., Freimer N.B., Friedl M., Georgieva L., Giegling I., Gill M., Glenthoj B., Godard S., Hamshere M., Hansen M., Hansen T., Hartmann A.M., Henskens F.A., Hougaard D.M., Hultman C.M., Ingason A., Jablensky A.V., Jakobsen K.D., Jay M., Jurgens G., Kahn R.S., Keller M.C., Kenis G., Kenny E., Kim Y., Kirov G.K., Konnerth H., Konte B., Krabbendam L., Krasucki R., Lasseter V.K., Laurent C., Lawrence J., Lencz T., Lerer F.B., Liang K.Y., Lichtenstein P., Lieberman J.A., Linszen D.H., Lonnqvist J., Loughland C.M., Maclean A.W., Maher B.S., Maier W., Mallet J., Malloy P., Mattheisen M., Mattingsdal M., Mcghee K.A., McGrath J.J., McIntosh A., McLean D.E., McQuillin A., Melle I., Michie P.T., Milanova V., Morris D.W., Mors O., Mortensen P.B., Moskvina V., Muglia P., Myin-Germeys I., Nertney D.A., Nestadt G., Nielsen J., Nikolov I., Nordentoft M., Norton N., Nothen M.M., O'Dushlaine C.T., Olincy A., Olsen L., O'Neill F.A., Orntoft T.F., Owen M.J., Pantelis C., Papadimitriou G., Pato M.T., Peltonen L., Petursson H., Pickard B., Pimm J., Pulver A.E., Puri V., Quested D., Quinn E.M., Rasmussen H.B., Rethelyi J.M., Ribble R., Rietschel M., Riley B.P., Ruggeri M., Schall U., Schulze T.G., Schwab S.G., Scott R.J., Shi J., Sigurdsson E., Silverman J.M., Spencer C.C., Stefansson K., Strange A., Strengman E., Stroup T.S., Suvisaari J., Terenius L., Thirumalai S., Thygesen J.H., Timm S., Toncheva D., van den O.E., van O.J., van W.R., Veldink J., Walsh D., Wang A.G., Wiersma D., Wildenauer D.B., Williams H.J., Williams N.M., Wormley B., Zammit S., Sullivan P.F., O'Donovan M.C., Daly M.J., Gejman P.V. Genome-wide association study identifies five new schizophrenia loci. Nat. Genet. 2011, 43:969-976.
42. Smrt R.D., Szulwach K.E., Pfeiffer R.L., Li X., Guo W., Pathania M., Teng Z.Q., Luo Y., Peng J., Bordey A., Jin P., Zhao X. MicroRNA miR-137 regulates neuronal maturation by targeting ubiquitin ligase mind bomb-1. Stem Cells 2010, 28:1060-1070.
43. Sullivan P.F., Kendler K.S., Neale M.C. Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch. Gen. Psychiatry 2003, 60:1187-1192.
44. Sun G., Ye P., Murai K., Lang M.F., Li S., Zhang H., Li W., Fu C., Yin J., Wang A., Ma X., Shi Y. miR-137 forms a regulatory loop with nuclear receptor TLX and LSD1 in neural stem cells. Nat. Commun. 2011, 2:529.
45. Szulwach K.E., Li X., Smrt R.D., Li Y., Luo Y., Lin L., Santistevan N.J., Li W., Zhao X., Jin P. Cross talk between microRNA and epigenetic regulation in adult neurogenesis. J. Cell Biol. 2010, 189:127-141.
46. Williams H.J., Norton N., Dwyer S., Moskvina V., Nikolov I., Carroll L., Georgieva L., Williams N.M., Morris D.W., Quinn E.M., Giegling I., Ikeda M., Wood J., Lencz T., Hultman C., Lichtenstein P., Thiselton D., Maher B.S., Malhotra A.K., Riley B., Kendler K.S., Gill M., Sullivan P., Sklar P., Purcell S., Nimgaonkar V.L., Kirov G., Holmans P., Corvin A., Rujescu D., Craddock N., Owen M.J., O'Donovan M.C. Fine mapping of ZNF804A and genome-wide significant evidence for its involvement in schizophrenia and bipolar disorder. Mol. Psychiatry 2011, 16:429-441.
47. Xiao F., Zuo Z., Cai G., Kang S., Gao X., Li T. miRecords: an integrated resource for microRNA-target interactions. Nucleic Acids Res. 2009, 37:D105-D110.
48. Xu B., Karayiorgou M., Gogos J.A. MicroRNAs in psychiatric and neurodevelopmental disorders. Brain Res. 2010, 1338:78-88.